Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis

by Krupa S. Jani, Shou‐En Lu, James D. Murphy, Paul B. Romesser, Krishan R. Jethwa, Diana Li, Anupama Chundury, Abraham J. Wu, Lara Hathout, Christopher L. Hallemeier, Salma K. Jabbour
Published 2021-06-01

The Impact of COVID-19 on Brachytherapy During the Pandemic: A Rutgers-Robert Wood Johnson Barnabas Health Multisite Experience

by Lara Hathout, MD, Ronald D. Ennis, MD, Malcolm D. Mattes, MD, Raquel T. Wagman, MD, Alison Grann, MD, Salma K. Jabbour, MD, Rachana Singh, MD, Ning J. Yue, PhD, Bruce G. Haffty, MD, Irina Vergalasova, PhD
Published 2021-01-01

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

by Lara Hathout, MD, FRCPC, Omar Mahmoud, MD, PhD, Yaqun Wang, PhD, Irina Vergalasova, PhD, Maroie Barkati, MD, FRCPC, Philippe Després, PhD, André-Guy Martin, MD, MSc, FRCPC, William Foster, MD, FRCPC, Frédéric Lacroix, PhD, Guila Delouya, MD, MSc, FRCPC, Daniel Taussky, MD, FRCPC, Gerard Morton, MD, FRCPC, Eric Vigneault, MD, MSc, FRCPC
Published 2019-10-01